Valuation: Codexis, Inc.

Market Cap 147M 128M 121M 110M 205M 14.05B 206M 1.44B 557M 7.14B 551M 539M 22.86B P/E 2026 *
-3.61x
P/E 2027 * -4.69x
Enterprise Value 147M 128M 121M 110M 205M 14.05B 206M 1.44B 557M 7.14B 551M 539M 22.86B EV / Sales 2026 *
1.98x
EV / Sales 2027 * 1.66x
Free-Float
92.88%
Yield 2026 *
-
Yield 2027 * -
1 day-1.49%
1 week-7.69%
Current month-22.35%
1 month-15.38%
3 months-46.77%
6 months-12.00%
Current year-19.02%
1 week 1.27
Extreme 1.27
1.5
1 month 1.27
Extreme 1.27
1.76
Current year 0.96
Extreme 0.9583
2.98
1 year 0.96
Extreme 0.9583
2.98
3 years 0.96
Extreme 0.9583
6.08
5 years 0.96
Extreme 0.9583
42.01
10 years 0.96
Extreme 0.9583
42.01
Manager TitleAgeSince
Chief Executive Officer 59 07/11/2025
Director of Finance/CFO 59 30/09/2024
Chief Tech/Sci/R&D Officer 56 05/05/2020
Director TitleAgeSince
Director/Board Member 66 01/03/2016
Director/Board Member 59 07/11/2025
Chairman 66 -
Date Insider Type Main position Quantity % Market Cap. Importance
2/23/26 A Free

Chief Financial Officer

316,100 0.3500%
2/23/26 A Sell

Chief Technology Officer

321,962 0.3565%
2/23/26 A Free

Chief Executive Officer

993,000 1.0994%
Change 5-day change 1-year change 3-year change Capi.($)
-1.49%-7.69%-46.99%-31.96% 147M
+1.23%+1.30%-0.69%+9.57% 45.91B
+0.23%+4.85%+44.23%+27.27% 44.25B
+0.52%-5.17%+340.58%+520.09% 41.99B
+1.55%+0.70%+8.03%+76.45% 39.58B
+1.75%-1.53%+12.22%+41.11% 31.08B
-0.20%+4.93%+25.35%+119.72% 17.21B
-3.49%-8.35% - - 16.27B
+2.92%+8.37%+22.73%+38.87% 14.96B
-2.45%+6.38%-1.99%-35.16% 13.42B
Average +0.17%+0.75%+44.83%+85.11% 26.48B
Weighted average by Cap. +0.77%+0.68%+71.08%+120.52%

Financials

2026 *2027 *
Net sales 74.09M 64.53M 61.07M 55.49M 104M 7.1B 104M 727M 281M 3.61B 278M 272M 11.54B 88.44M 77.03M 72.9M 66.24M 124M 8.47B 124M 868M 336M 4.3B 332M 325M 13.78B
Net income -36.35M -31.66M -29.97M -27.23M -50.86M -3.48B -51.11M -357M -138M -1.77B -137M -134M -5.66B -28.54M -24.86M -23.53M -21.38M -39.94M -2.73B -40.13M -280M -108M -1.39B -107M -105M -4.45B
Net Debt - -
Logo Codexis, Inc.
Codexis, Inc. is a provider of enzymatic solutions. It is leveraging its CodeEvolver technology platform to discover, develop, enhance, and commercialize novel, high-performance enzymes and other classes of proteins. The Company utilizes its CodeEvolver technology platform to develop optimized enzymes that are used by some pharmaceutical companies to reduce their costs and improve the efficiency and productivity of their manufacturing processes for small molecule therapeutics. It is developing its Enzyme-Catalyzed Oligonucleotide Synthesis (ECO Synthesis) manufacturing platform to enable the scaled manufacture of RNA interference (RNAi) and other RNA-based therapeutics through an enzymatic route. The Company also uses the CodeEvolver platform technology to develop enzymes for the synthesis of RNAi therapeutics through its ECO Synthesis manufacturing platform, where its enzymes are poised to deliver many of the same benefits it offers in pharmaceutical manufacturing.
Employees
146
Date Price Change Volume
17/09/26 $1.320 -1.49% 1,181,437
16/09/26 $1.340 -4.29% 954,278
15/09/26 $1.400 -5.41% 608,727
14/09/26 $1.480 +1.02% 477,570
11/09/26 $1.465 +1.74% 505,062
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
1.340USD
Average target price
6.333USD
Spread / Average Target
+372.64%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CDXS Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!